Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OPIATE DEPENDENCE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Barrio, G; De La Fuente, L; Lew, C; Royuela, L; Bravo, MJ; Torrens, M
      Differences in severity of heroin dependence by route of administration: the importance of length of heroin use

      DRUG AND ALCOHOL DEPENDENCE
    2. Shichinohe, S; Ozawa, H; Hashimoto, E; Tatschner, T; Riederer, P; Saito, T
      Changes in the cAMP-related signal transduction mechanism in postmortem human brains of heroin addicts

      JOURNAL OF NEURAL TRANSMISSION
    3. Lu, L; Huang, MS; Ma, L; Li, J
      Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats

      BEHAVIOURAL BRAIN RESEARCH
    4. Miles, DR; Svikis, DS; Kulstad, JL; Haug, NA
      Psychopathology in pregnant drug-dependent women with and without comorbidalcohol dependence

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    5. Dennison, SJ
      Clonidine abuse among opiate addicts

      PSYCHIATRIC QUARTERLY
    6. Coupar, IM; Tran, BLT
      Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine

      LIFE SCIENCES
    7. Lu, L; Su, WJ; Yue, W; Ge, X; Su, F; Pei, G; Ma, L
      Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor

      LIFE SCIENCES
    8. Curran, HV; Kleckham, J; Bearn, J; Strang, J; Wanigaratne, S
      Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study

      PSYCHOPHARMACOLOGY
    9. Rittmannsberger, H; Silberbauer, C; Lehner, R; Ruschak, M
      Alcohol consumption during methadone maintenance treatment

      EUROPEAN ADDICTION RESEARCH
    10. Ross, J; Darke, S
      The nature of benzodiazepine dependence among heroin users in Sydney, Australia

      ADDICTION
    11. Chadderton, A
      Clinical issues in using buprenorphine in the treatment of opiate dependence

      DRUG AND ALCOHOL REVIEW
    12. Georges, F; Stinus, L; Le Moine, C
      Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved

      EUROPEAN JOURNAL OF NEUROSCIENCE
    13. Zubieta, JK; Greenwald, MK; Lombardi, U; Woods, JH; Kilbourn, MR; Jewett, DM; Koeppe, RA; Schuster, CR; Johanson, CE
      Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: A preliminary study

      NEUROPSYCHOPHARMACOLOGY
    14. Galloway, GP; Frederick-Osborne, SL; Seymour, R; Contini, SE; Smith, DE
      Abuse and therapeutic potential of gamma-hydroxybutyric acid

      ALCOHOL
    15. Leo, RJ; Narendran, R; DeGuiseppe, B
      Methadone detoxification of tramadol dependence

      JOURNAL OF SUBSTANCE ABUSE TREATMENT
    16. Sell, LA; Morris, JS; Bearn, J; Frackowiak, RSJ; Friston, KJ; Dolan, RJ
      Neural responses associated with cue evoked emotional states and heroin inopiate addicts

      DRUG AND ALCOHOL DEPENDENCE
    17. Miele, GM; Carpenter, KM; Cockerham, MS; Trautman, KD; Blaine, J; Hasin, DS
      Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders

      DRUG AND ALCOHOL DEPENDENCE
    18. Kilpatrick, B; Howlett, M; Sedgwick, P; Ghodse, AH
      Drug use, self report and urinalysis

      DRUG AND ALCOHOL DEPENDENCE
    19. Huang, EYK; Li, JY; Tan, PPC; Wong, CH; Chen, JC
      The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF)

      PEPTIDES
    20. Boehle, C; Kindgen-Milles, D; Burtscheidt, W; Tarnow, J; Gaebel, W
      Report on clinical experience with antagonist-induced opiate detoxification and short and medium term follow-up

      NERVENARZT
    21. Bohn, LM; Gainetdinov, RR; Lin, FT; Lefkowitz, RJ; Caron, MG
      mu-Opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence

      NATURE
    22. Malin, DH; Lake, JR; Moon, WD; Moy, D; Montellano, AL; Moy, E; Campbell, TD; Bell, MV; Bryant, D; Harrison, LM; Grandy, DK
      Nociceptin/orphanin FQ (N/OFQ) induces a quasi-morphine abstinence syndrome in the rat

      PSYCHOPHARMACOLOGY
    23. Shippenberg, TS; Funada, M; Schutz, CG
      Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat

      PSYCHOPHARMACOLOGY
    24. DeMaria, PA; Serota, RD
      A therapeutic use of the methadone fluvoxamine drug interaction

      JOURNAL OF ADDICTIVE DISEASES
    25. Crome, IB
      Substance misuse and psychiatric comorbidity: towards improved service provision

      DRUGS-EDUCATION PREVENTION AND POLICY
    26. Franken, IHA; de Haan, HA; Van der Meer, CW; Haffmans, PMJ; Hendriks, VM
      Cue reactivity and effects of cue exposure in abstinent posttreatment drugusers

      JOURNAL OF SUBSTANCE ABUSE TREATMENT
    27. Crome, IB
      Treatment interventions - looking towards the millennium

      DRUG AND ALCOHOL DEPENDENCE
    28. Allard, M; Rousselot, P; Lombard, MC; Theodosis, DT
      Evidence for neuropeptide FF (FLFQPQRFamide) in rat dorsal root ganglia

      PEPTIDES
    29. Tan, PPC; Chen, JC; Li, JY; Liang, KW; Wong, CH; Huang, EYK
      Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs

      PEPTIDES
    30. Capasso, A
      Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by mu, kappa and delta opioid agonists in isolated tissues

      NEUROPHARMACOLOGY
    31. Basilico, L; Parolaro, D; Colleoni, M; Costa, B; Giagnoni, G
      Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexus

      EUROPEAN JOURNAL OF PHARMACOLOGY
    32. Liu, JG; Liao, XP; Gong, ZH; Qin, BY
      Methadone-induced desensitization of the delta-opioid receptor is mediatedby uncoupling of receptor from G protein

      EUROPEAN JOURNAL OF PHARMACOLOGY
    33. Raghavendra, V; Kulkarni, SK
      Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors

      BRAIN RESEARCH
    34. Jang, CG; Rockhold, RW; Ho, IK
      Withdrawal from butorphanol dependence alters binding of [H-3]phorbol dibutyrate to protein kinase C, but not of [H-3]forskolin to adenylate cyclase

      BRAIN RESEARCH
    35. Lombard, MC; Weil-Fugazza, J; Ries, C; Allard, M
      Unilateral joint inflammation induces bilateral and time-dependent changesin neuropeptide FF binding in the superficial dorsal horn of the rat spinal cord: implication of supraspinal descending systems

      BRAIN RESEARCH
    36. Mendelson, J; Jones, RT; Welm, S; Baggott, M; Fernandez, I; Melby, AK; Nath, RP
      Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

      PSYCHOPHARMACOLOGY
    37. KAN CC; BRETELER MHM; VANDERVEN AHGS; ZITMAN FG
      AN EVALUATION OF DSM-III-R AND ICD-10 BENZODIAZEPINE DEPENDENCE CRITERIA USING RASCH MODELING

      Addiction
    38. FOY A; SADLER C; TAYLOR A
      AN OPEN TRIAL OF NALTREXONE FOR OPIATE DEPENDENCE

      Drug and alcohol review
    39. SCHULTEIS G; STINUS L; RISBROUGH VB; KOOB GF
      CLONIDINE BLOCKS ACQUISITION BUT NOT EXPRESSION OF CONDITIONED OPIATEWITHDRAWAL IN RATS

      Neuropsychopharmacology
    40. NUNES EV; WEISSMAN MM; GOLDSTEIN RB; MCAVAY G; SERACINI AM; VERDELI H; WICKRAMARATNE PJ
      PSYCHOPATHOLOGY IN CHILDREN OF PARENTS WITH OPIATE DEPENDENCE AND OR MAJOR DEPRESSION/

      Journal of the American Academy of Child and Adolescent Psychiatry
    41. ROSSE RB; JOHRI S; GOEL M; RAHMAN F; JAWOR KA; DEUTSCH SI
      PUPILLOMETRIC CHANGES DURING GRADUAL OPIATE DETOXIFICATION CORRELATE WITH CHANGES IN SYMPTOMS OF OPIATE WITHDRAWAL AS MEASURED BY THE WEAK OPIATE WITHDRAWAL SCALE

      Clinical neuropharmacology
    42. BOUNDY VA; GOLD SJ; MESSER CJ; CHEN JS; SON JH; JOH TH; NESTLER EJ
      REGULATION OF TYROSINE-HYDROXYLASE PROMOTER ACTIVITY BY CHRONIC MORPHINE IN TH9.0-LACZ TRANSGENIC MICE

      The Journal of neuroscience
    43. BROWN AS; FLEMING PM
      A NATURALISTIC STUDY OF HOME DETOXIFICATION FROM OPIATES USING LOFEXIDINE

      JOURNAL OF PSYCHOPHARMACOLOGY
    44. SCHULTEIS G; YACKEY M; RISBROUGH V; KOOB GF
      ANXIOGENIC-LIKE EFFECTS OF SPONTANEOUS AND NALOXONE-PRECIPITATED OPIATE WITHDRAWAL IN THE ELEVATED PLUS-MAZE

      Pharmacology, biochemistry and behavior
    45. CAMMARANO WB; PITTET JF; WEITZ S; SCHLOBOHM RM; MARKS JD
      ACUTE WITHDRAWAL SYNDROME-RELATED TO THE ADMINISTRATION OF ANALGESIC AND SEDATIVE MEDICATIONS IN ADULT INTENSIVE-CARE UNIT PATIENTS

      Critical care medicine
    46. PINEDA J; TORRECILLA M; MARTINRUIZ R; UGEDO L
      ATTENUATION OF WITHDRAWAL-INDUCED HYPERACTIVITY OF LOCUS-COERULEUS NEURONS BY INHIBITORS OF NITRIC-OXIDE SYNTHASE IN MORPHINE-DEPENDENT RATS

      Neuropharmacology
    47. CAPASSO A; SORRENTINO L; PINTO A
      THE ROLE OF NITRIC-OXIDE IN THE DEVELOPMENT OF OPIOID WITHDRAWAL INDUCED BY NALOXONE AFTER ACUTE TREATMENT WITH MU-OPIOID AND K-OPIOID RECEPTOR AGONISTS

      European journal of pharmacology
    48. GELOT A; FRANCES B; GICQUEL S; ZAJAC JM
      ANTISENSE OLIGONUCLEOTIDES TO HUMAN SQA-NEUROPEPTIDE FF DECREASE MORPHINE-TOLERANCE AND DEPENDENCE IN MICE

      European journal of pharmacology
    49. Kaplan, GB; Coyle, TS
      Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    50. GELOT A; FRANCES B; ROUSSIN A; LATAPIE JP; ZAJAC JM
      ANTI-OPIOID EFFICACY OF NEUROPEPTIDE FF IN MORPHINE-TOLERANT MICE

      Brain research
    51. KAPLAN GB; LEITEMORRIS KA; SETHI RK; MCCLELLAND EG
      REGULATION OF G PROTEIN-MEDIATED ADENYLYL-CYCLASE IN STRIATUM AND CORTEX OF OPIATE-DEPENDENT AND OPIATE WITHDRAWING MICE

      Brain research
    52. BELL JA; GRANT SJ
      LOCUS-COERULEUS NEURONS FROM MORPHINE-TREATED RATS DO NOT SHOW OPIATE-WITHDRAWAL HYPERACTIVITY IN-VITRO

      Brain research
    53. LERNER AG; GELKOPF M; SIGAL M; OYFFE I
      INDICATORS OF GOOD PROGNOSIS IN NALTREXONE TREATMENT - A 5-YEAR PROSPECTIVE-STUDY

      Addiction research
    54. CROME IB
      YOUNG-PEOPLE AND SUBSTANCE PROBLEMS - FROM IMAGE TO IMAGINATION

      Drugs: education, prevention policy
    55. TOPP L; MATTICK RP
      CHOOSING A CUTOFF ON THE SEVERITY OF DEPENDENCE SCALE (SDS) FOR AMPHETAMINE USERS

      Addiction
    56. TOPP L; MATTICK RP
      VALIDATION OF THE AMPHETAMINE DEPENDENCE SYNDROME AND THE SAMDQ

      Addiction
    57. TEJERO A; TRUJOLS J; HERNANDEZ E; DELOSCOBOS JP; CASAS M
      PROCESSES OF CHANGE ASSESSMENT IN HEROIN-ADDICTS FOLLOWING THE PROCHASKA AND DICLEMENTE TRANSTHEORETICAL MODEL

      Drug and alcohol dependence
    58. WOLFF K; ROSTAMIHODJEGAN A; SHIRES S; HAY AWM; FEELY M; CALVERT R; RAISTRICK D; TUCKER GT
      THE PHARMACOKINETICS OF METHADONE IN HEALTHY-SUBJECTS AND OPIATE USERS

      British journal of clinical pharmacology
    59. PUNCH LJ; SELF DW; NESTLER EJ; TAYLOR JR
      OPPOSITE MODULATION OF OPIATE WITHDRAWAL BEHAVIORS ON MICROINFUSION OF A PROTEIN-KINASE-A INHIBITOR VERSUS ACTIVATOR INTO THE LOCUS-COERULEUS OR PERIAQUEDUCTAL GRAY

      The Journal of neuroscience
    60. GASTFRIEND DR; MCLELLAN AT
      TREATMENT MATCHING - THEORETIC BASIS AND PRACTICAL IMPLICATIONS

      The Medical clinics of North America
    61. REDDY DS; KULKARNI SK
      CHRONIC NEUROSTEROID TREATMENT PREVENTS THE DEVELOPMENT OF MORPHINE-TOLERANCE AND ATTENUATES ABSTINENCE BEHAVIOR IN MICE

      European journal of pharmacology
    62. DUPOUY V; ZAJAC JM
      NEUROPEPTIDE FF RECEPTORS CONTROL MORPHINE-INDUCED ANALGESIA IN THE PARAFASCICULAR NUCLEUS AND THE DORSAL RAPHE NUCLEUS

      European journal of pharmacology
    63. CAPASSO A; SORRENTINO L
      ARACHIDONIC-ACID AND ITS METABOLITES ARE INVOLVED IN THE EXPRESSION OF MORPHINE-DEPENDENCE IN GUINEA-PIG ISOLATED ILEUM

      European journal of pharmacology
    64. LIEBMANN PM; LEHOFER M; MOSER M; HOEHNSARIC R; LEGL T; PERNHAUPT G; SCHAUENSTEIN K
      PERSISTENT ANALGESIA IN FORMER OPIATE ADDICTS IS RESISTANT TO BLOCKADE OF ENDOGENOUS OPIOIDS

      Biological psychiatry
    65. SHOEMAKER WJ; KOSTEN TA; MULY SM
      ETHANOL ATTENUATION OF MORPHINE-DEPENDENCE - COMPARISON TO DIZOCILPINE

      Psychopharmacology
    66. ROSS J; DARKE S; HALL W
      BENZODIAZEPINE USE AMONG HEROIN USERS IN SYDNEY - PATTERNS OF USE, AVAILABILITY AND PROCUREMENT

      Drug and alcohol review
    67. DARKE S; FINLAYJONES R; KAYE S; BLATT T
      ANTISOCIAL PERSONALITY-DISORDER AND RESPONSE TO METHADONE-MAINTENANCETREATMENT

      Drug and alcohol review
    68. CAPASSO A; AQUINO R; DESIMONE F; SORRENTINO L
      EXTRACT FROM SICKINGIA-WILLIAMSII REDUCES MORPHINE-WITHDRAWAL IN-VITRO

      PTR. Phytotherapy research
    69. ORTI RM; DOMINGOSALVANY A; MUNOZ A; MACFARLANE D; SUELVES JM; ANTO JM
      MORTALITY TRENDS IN A COHORT OF OPIATE ADDICTS, CATALONIA, SPAIN

      International journal of epidemiology
    70. MALIN DH; LAKE JR; JONES JA; MOREL J; MOON WD; CORBIT BP; SMITH DA; CLAUNCH AE; KACHER D; STEVENS PA; WEBB SL
      NITRIC-OXIDE SYNTHESIS INHIBITION ATTENUATES BEHAVIORAL ACTIONS OF NEUROPEPTIDE FF

      Peptides
    71. MALIN DH; LAKE JR; MCDERMITT LS; SMITH DA; WITHERSPOON WE; JONES JA; SCHUMANN MD; PAYZA K; HO KK; BURGESS K
      ENHANCED ANTIOPIATE ACTIVITY AND ENZYME RESISTANCE IN A PEPTIDOMIMETIC OF FMRFAMIDE CONTAINING E-2,3-METHANOMETHIONINE AND E-2,3-METHANOPHENYLALANINE

      Peptides
    72. SCHNEIDER C; FISCHER G; DIAMANT K; HAUK R; PEZAWAS L; LENZINGER E; KASPER S
      PREGNANCY AND DRUG-ABUSE

      Wiener Klinische Wochenschrift
    73. LEZA JC; LIZASOAIN I; CUELLAR B; MORO MA; LORENZO P
      CORRELATION BETWEEN BRAIN NITRIC-OXIDE SYNTHASE ACTIVITY AND OPIATE WITHDRAWAL

      Naunyn-Schmiedeberg's archives of pharmacology
    74. AMMER H; SCHULZ R
      MORPHINE-DEPENDENCE IN HUMAN NEUROBLASTOMA SH-SY5Y CELLS IS ASSOCIATED WITH ADAPTIVE-CHANGES IN BOTH THE QUANTITY AND FUNCTIONAL INTERACTION OF PGE(1) RECEPTORS AND STIMULATORY G-PROTEINS

      Brain research
    75. GOSSOP M; DARKE S; GRIFFITHS P; HANDO J; POWIS B; HALL W; STRANG J
      THE SEVERITY OF DEPENDENCE SCALE (SDS) - PSYCHOMETRIC PROPERTIES OF THE SDS IN ENGLISH AND AUSTRIAN SAMPLES OF HEROIN, COCAINE AND AMPHETAMINE USERS

      Addiction
    76. STEPHENS DN
      A GLUTAMATERGIC HYPOTHESIS OF DRUG-DEPENDENCE - EXTRAPOLATIONS FROM BENZODIAZEPINE RECEPTOR LIGANDS

      Behavioural pharmacology
    77. TRUJILLO KA
      EFFECTS OF NONCOMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS ON OPIATE TOLERANCE AND PHYSICAL-DEPENDENCE

      Neuropsychopharmacology
    78. HOLMES PV; DEBARTOLOMEIS A; KOPRIVICA V; CRAWLEY JN
      LACK OF EFFECT OF CHRONIC MORPHINE TREATMENT AND NALOXONE-PRECIPITATED WITHDRAWAL ON TYROSINE-HYDROXYLASE, GALANIN, AND NEUROPEPTIDE-Y MESSENGER-RNA LEVELS IN THE RAT LOCUS-COERULEUS

      Synapse
    79. DELAGARZA MFO; SORENSEN JL
      A SELF-HELP GROUP FOR DRUG-ADDICTED CLIENTS - ASSISTED IMPLEMENTATIONIN OUTPATIENT TREATMENT

      Journal of substance abuse treatment
    80. MALIN DH; LAKE JR; SMITH DA; JONES JA; MOREL J; CLAUNCH AE; STEVENS PA; PAYZA K; HO KK; LIU J; HAM I; BURGESS K
      SUBCUTANEOUS INJECTION OF AN ANALOG OF NEUROPEPTIDE FF PREVENTS NALOXONE-PRECIPITATED MORPHINE ABSTINENCE SYNDROME

      Drug and alcohol dependence
    81. STINUS L; ALLARD M; GOLD L; SIMONNET G
      CHANGES IN CNS NEUROPEPTIDE FF-LIKE MATERIAL, PAIN SENSITIVITY, AND OPIATE DEPENDENCE FOLLOWING CHRONIC MORPHINE TREATMENT

      Peptides
    82. GALLIMBERTI L; SCHIFANO F; FORZA G; MICONI L; FERRARA SD
      CLINICAL EFFICACY OF GAMMA-HYDROXYBUTYRIC ACID IN TREATMENT OF OPIATEWITHDRAWAL

      European archives of psychiatry and clinical neuroscience
    83. SIMPKINS JW
      EFFECTS OF AGING ON MORPHINE-WITHDRAWAL IN THE RAT

      Experimental gerontology
    84. CARROLL KM; ROUNSAVILLE BJ; BRYANT KJ
      SHOULD TOLERANCE AND WITHDRAWAL BE REQUIRED FOR SUBSTANCE DEPENDENCE DISORDERS

      Drug and alcohol dependence
    85. ADAMS RE; WOOTEN GF
      REGIONAL CEREBRAL GLUCOSE-UTILIZATION IN WITHDRAWAL FOLLOWING SYSTEMIC AND INTRACEREBROVENTRICULAR SUFENTANIL ADMINISTRATION

      Neurochemical research
    86. SELF DW; TERWILLIGER RZ; NESTLER EJ; STEIN L
      INACTIVATION OF G(I) AND G(O) PROTEINS IN NUCLEUS-ACCUMBENS REDUCES BOTH COCAINE AND HEROIN REINFORCEMENT

      The Journal of neuroscience
    87. PORTENOY RK
      TOLERANCE TO OPIOID ANALGESICS - CLINICAL ASPECTS

      Cancer surveys
    88. SCHNUR P; ESPINOZA M; FLORES R
      CONTEXT-SPECIFIC SENSITIZATION TO NALOXONE-PRECIPITATED WITHDRAWAL INHAMSTERS - EFFECT OF PIMOZIDE

      Pharmacology, biochemistry and behavior
    89. BRONSON ME
      CHLORDIAZEPOXIDE, BUT NOT BRETAZENIL, PRODUCES ACUTE DEPENDENCE, AS EVIDENCED BY DISRUPTIONS IN SCHEDULE-CONTROLLED BEHAVIOR

      Pharmacology, biochemistry and behavior
    90. MCLACHLAN CD; HAY M; COLEMAN GJ
      THE EFFECTS OF EXERCISE ON THE ORAL CONSUMPTION OF MORPHINE AND METHADONE IN RATS

      Pharmacology, biochemistry and behavior
    91. WANG Z; BILSKY EJ; PORRECA F; SADEE W
      CONSTITUTIVE MU-OPIOID RECEPTOR ACTIVATION AS A REGULATORY MECHANISM UNDERLYING NARCOTIC TOLERANCE AND DEPENDENCE

      Life sciences
    92. KAPLAN GB; LEITEMORRIS KA; SEARS MT
      ALTERATIONS OF ADENOSINE A(1) RECEPTORS IN MORPHINE-DEPENDENCE

      Brain research
    93. CHURCHILL AC; BURGESS PM; PEAD J; GILL T
      MEASUREMENT OF THE SEVERITY OF AMPHETAMINE DEPENDENCE

      Addiction
    94. GOSSOP M; GRIFFITHS P; POWIS B; STRANG J
      SEVERITY OF HEROIN DEPENDENCE AND HIV RISK .1. SEXUAL-BEHAVIOR

      AIDS care
    95. GOSSOP M; GRIFFITHS P; POWIS B; STRANG J
      SEVERITY OF HEROIN DEPENDENCE AND HIV RISK .2. SHARING INJECTING EQUIPMENT

      AIDS care
    96. KRYLOVA OY; SHAMAKINA IY; ANOKHIN KV
      REGULATION OF C-FOS EXPRESSION BY ACUTE AND CHRONIC MORPHINE ADMINISTRATION IN RAT-BRAIN

      Neuroscience research communications
    97. HARRIS GC; ASTONJONES G
      BETA-ADRENERGIC ANTAGONISTS ATTENUATE SOMATIC AND AVERSIVE SIGNS OF OPIATE WITHDRAWAL

      Neuropsychopharmacology
    98. GALLIMBERTI L; CIBIN M; PAGNIN P; SABBION R; PANI PP; PIRASTU R; FERRARA SD; GESSA GL
      GAMMA-HYDROXYBUTYRIC ACID FOR TREATMENT OF OPIATE WITHDRAWAL SYNDROME

      Neuropsychopharmacology
    99. VACCARINO AL; COURET LC
      FORMALIN-INDUCED PAIN ANTAGONIZES THE DEVELOPMENT OF OPIATE DEPENDENCE IN THE RAT

      Neuroscience letters
    100. MALIN DH; LAKE JR; PAYZA K; CORRIERE LS; BENSON TM; GARBER TL; WALLER ML; LUU TA; KELLEY RS; SMITH DA; HO KK; BURGESS K
      ENHANCED ANTIOPIATE ACTIVITY AND ENZYME RESISTANCE IN PEPTIDOMIMETICSOF FMRFAMIDE CONTAINING (E)-2,3-METHANOMETHIONINE

      Peptides


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 23:23:14